Cervical cancer in the screening era: Who fell victim in spite of successful screening programs?

Journal of Gynecologic Oncology

Volumn 22, Issue 2, 2011, Pages 76-82

  Pettersson, B Folke ^a   Hellman, Kristina ^a   Vaziri, Roxane ^a   Andersson, Sonia ^a   Hellström, Ann Cathrin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Age; Cervical cancer; Histology; Screening; Stage

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CARCINOMA IN SITU; EARLY DIAGNOSIS; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION;

EID: 80052005078     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2011.22.2.76     Document Type: Article

References (36)

1. Boyes DA, Knowelden J, Phillips AJ. The evaluation of cancer control measures. Br J Cancer 1973;28:105-107.
2. Christopherson WM, Parker JE, Mendez WM, Lundin FE Jr. Cervix cancer death rates and mass cytologic screening. Cancer 1970;26:808-811.
3. Dillner J. Cervical cancer screening in Sweden. Eur J Cancer 2000;36:2255-2259.
4. Pettersson F, Bjorkholm E, Naslund I. Evaluation of screening for cervical cancer in Sweden: trends in incidence and mortality 1958-1980. Int J Epidemiol 1985;14:521-527.
5. Pettersson F, Naslund I, Malker B. Evaluation of the effect of Papanicolaou screening in Sweden: record linkage between a central screening registry and the National Cancer Registry. IARC Sci Publ 1986;(76):91-105.
6. The National Board of Health and Welfare. Statistics Sweden. Stockholm: The National Board of Health and Welfare; 1976.
7. Pettersson F. Secondary prevention: screening for carcinoma of the uterine cervix. In: Kavanagh JJ, Singletary SE, Einhorn N, DePetrillo AD, editors. Cancer in women. Cambridge, MA: Blackwell Science; 1998. p. 240-50.
8. The National Board of Health and Welfare. Cancer Incidence in Sweden 2008. Stockholm: The National Board of Health and Welfare; 2009.
9. Pettersson F. Annual report on the results of treatment in gynecologic cancer FIGO 1994. Stockholm: Radiumhemmet; 1995.
10. World Health Organization. Use of screening for cervical cancer: cervical cancer screening. Lyon: IARC Press; 2005.
11. Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ. Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 2005; 113:1005-9.
12. The National Board of Health and Welfare. Socialstyrelsen: Statistics of Sweden [Internet]. Stockholm: Socialstyrelsen; [cited 2011 May 20]. Available from: http://www.sos.se.
13. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118:1481-95.
14. Berrington de Gonzalez A, Sweetland S, Green J. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis. Br J Cancer 2004;90:1787-91.
15. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 2003;14:805-14.
16. Pettersson BF. Adenocarcinoma of the uterine cervix. Changes in incidence. A cancer registry study [abstract]. Paper presented at: 38th Annual Meeting of the Society of Pelvic Surgeons; October 5-8, 1988; Toronto, ON.
17. Bergstrom R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 1999;81:159-166.
18. Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet 2001;357:1490-3.
19. Sasieni P, Castanon A, Cuzick J. Screening and adenocarcinoma of the cervix. Int J Cancer 2009;125:525-9.
20. Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005;14:2191-9.
21. Babes A. Diagnostic du cancer du col uterin par Les-Frottis. Presse Med 1928;36:451-4.
22. Naslund I, Auer G, Pettersson F, Sjovall K. Evaluation of the pulse wash sampling technique for screening of uterine cervical carcinoma. Acta Radiol Oncol 1986;25:131-6.
23. Zielinski GD, Snijders PJ, Rozendaal L, Daalmeijer NF, Risse EK, Voorhorst FJ, et al. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. J Pathol 2003;201:535-43.
24. Brismar S, Johansson B, Borjesson M, Arbyn M, Andersson S. Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping. Am J Obstet Gynecol 2009;201:17.e1-17.e8.
25. Gustafsson L, Sparen P, Gustafsson M, Pettersson B, Wilander E, Bergstrom R, et al. Low efficiency of cytologic screening for cancer in situ of the cervix in older women. Int J Cancer 1995;63:804-809.
26. Gyllensten U, Lindell M, Gustafsson I, Wilander E. HPV test shows low sensitivity of Pap screen in older women. Lancet Oncol 2010;11:509-510.
27. Andrae B, Kemetli L, Sparen P, Silfverdal L, Strander B, Ryd W, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008;100:622-9.
28. Anttila A, Ronco G; Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE). Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009; 45:2685-708.
29. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009;20:417-35.
30. Jensen KE, Hannibal CG, Nielsen A, Jensen A, Nohr B, Munk C, et al. Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003. Eur J Cancer 2008;44:2003-2017.
31. van der Aa MA, Siesling S, Louwman MW, Visser O, Pukkala E, Coebergh JW. Geographical relationships between sociodemographic factors and incidence of cervical cancer in the Netherlands 1989-2003. Eur J Cancer Prev 2008;17:453-459.
32. Eaker S, Adami HO, Sparen P. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med 2001;32:482-491.
33. Idestrom M, Milsom I, Andersson-Ellstrom A. Knowledge and attitudes about the Pap-smear screening program: a population-based study of women aged 20-59 years. Acta Obstet Gynecol Scand 2002;81:962-927.
34. Pettersson F, Malker B. Invasive carcinoma of the uterine cervix following diagnosis and treatment of in situ carcinoma: record linkage study within a National Cancer Registry. Radiother Oncol 1989;16:115-120.
35. Hellstrom AC, Sigurjonson T, Pettersson F. Carcinoma of the cervical stump. The radiumhemmet series 1959-1987: treatment and prognosis. Acta Obstet Gynecol Scand 2001;80:152-157.
36. Pettersson BF, Andersson S, Hellman K, Hellstrom AC. Invasive carcinoma of the uterine cervix associated with pregnancy: 90 years of experience. Cancer 2010;116:2343-2349.